Financings in Brief: PerSeptive Biosystems
This article was originally published in The Gray Sheet
Executive Summary
PerSeptive Biosystems: Redeems 1,000 shares of preferred stock held by Millipore for 1.25 mil. shares of common stock valued at $8 each. The preferred stock was issued in connection with the acquisition of Millipore's BioSearch division by PerSeptive in August 1994 ("The Gray Sheet" July 18, 1994, In Brief). The payment is valued at $10 mil...
You may also be interested in...
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.
Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel
Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.